000			01725 a2200493 4500
005			20250514215956.0
264		0	_c20051005
008			200510s 0 0 eng d
022			_a1527-9995
024	7		_a10.1016/j.urology.2004.09.030 _2doi
040			_aNLM _beng _cNLM
100	1		_aMochtar, C A
245	0	0	_aPrognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting. _h[electronic resource]
260			_bUrology _cFeb 2005
300			_a300-5 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAdrenergic alpha-Antagonists _xtherapeutic use
650	0	4	_aAged
650	0	4	_aBiomarkers _xblood
650	0	4	_aCase Management
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aLife Tables
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOrgan Size
650	0	4	_aPrognosis
650	0	4	_aProportional Hazards Models
650	0	4	_aProstate _xpathology
650	0	4	_aProstate-Specific Antigen _xblood
650	0	4	_aProstatectomy _xstatistics & numerical data
650	0	4	_aProstatic Hyperplasia _xblood
650	0	4	_aRisk
650	0	4	_aUrinary Bladder Neck Obstruction _xetiology
650	0	4	_aUrinary Retention _xetiology
700	1		_aKiemeney, L A L M
700	1		_aLaguna, M P
700	1		_avan Riemsdijk, M M
700	1		_aBarnett, G S
700	1		_aDebruyne, F M J
700	1		_ade la Rosette, J J M C H
773	0		_tUrology _gvol. 65 _gno. 2 _gp. 300-5
856	4	0	_uhttps://doi.org/10.1016/j.urology.2004.09.030 _zAvailable from publisher's website
999			_c15384021 _d15384021